Mineralys Therapeutics (MLYS) Book Value
Market Cap: $865.45M
Avg Volume: 1.12M
Industry: Biotechnology
Sector: Healthcare
What is Mineralys Therapeutics's Book Value?
- Mineralys Therapeutics's annual Book Value is $191.26M.
- Mineralys Therapeutics's quarterly Book Value is $191.26M.
What is Book Value?
Book Value represents the total value of a company's assets that shareholders would theoretically receive if a company were liquidated. It is calculated as the total assets minus intangible assets and total liabilities.
How is Book Value calculated?
Book Value is calculated using the following formula:
Book Value = Total Assets - Intangible Assets - Total Liabilities
Related Metrics
Other important metrics to assess Mineralys Therapeutics's financial health include:
- Book Value per Share - measures the per-share value of a company based on its equity:
- Annual: $3.94
- Quarterly: $3.83
- Tangible Book Value per Share - measures the per-share value of a company's tangible assets:
- Annual: $3.94
- Quarterly: $3.83
These metrics provide insights into Mineralys Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Book Value
$191.26M
Quarterly Book Value
$191.26M
Mineralys Therapeutics Historical Book Value
Historical Book Value per Share
Historical Tangible Book Value per Share
Mineralys Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Book Value | Book Value Change | Book Value per Share | Tangible Book Value per Share |
|---|---|---|---|---|
| 2024 | $191.26M | -20.69% | 3.94 | 3.94 |
| 2023 | $241.15M | -561.37% | 6.66 | 6.66 |
| 2022 | $-52.27M | 128.00% | -1.28 | -1.28 |
| 2021 | $-22.93M | 537.34% | -0.59 | -0.59 |
| 2020 | $-3.60M | N/A | -0.09 | -0.09 |
Related Metrics
Explore detailed financial metrics and analysis for MLYS.